Patents
Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
05/1997
05/22/1997CA2237993A1 Peptide conjugates, use thereof as a drug, and compositions containing same
05/22/1997CA2234661A1 Mimotopes and anti-mimotopes of human platelet glycoprotein ib/ix
05/22/1997CA2232876A1 Fas ligand fusion protein
05/21/1997EP0774260A1 Remedy for corneal diseases
05/21/1997EP0774120A1 Peptides marked with metal chelates
05/21/1997EP0773956A1 Purified form of streptogramines, preparation of same and pharmaceutical compositions containing same
05/21/1997EP0773952A1 Interaction trap systems for detecting protein interactions
05/21/1997EP0773950A1 Linked peptide nucleic acids
05/21/1997EP0773790A1 Invariant chain compositions useful for treating autoimmune diseases
05/21/1997EP0773787A1 HLA binding peptides and their uses
05/21/1997CN1034943C Process for preparing cyclic vasoactive peptides
05/20/1997US5631229 Method for inactivating gonadotrophs
05/20/1997US5631228 Anti-fungal and anti-bacterial histatin-based peptides
05/20/1997US5631223 Cyclic oligopeptides
05/20/1997US5631222 Treatment of asthma, angina pectoris, cardiovascular and brain disorders; hypotensive agents
05/15/1997WO1997017470A1 Detection of mammary tumor virus-like sequences in human breast cancer
05/15/1997WO1997017365A1 Cyclohexapeptidyl bisamine compound, compositions containing said compound and methods of use
05/15/1997WO1997017364A1 Peptide derivatives of dolastatin 15 and their use
05/15/1997WO1997001576A3 Phenyl peptides, method for preparing same, and pharmaceutical compositions containing said peptides
05/15/1997CA2235824A1 Cyclohexapeptidyl bisamine compound, compositions containing said compound and methods of use
05/14/1997EP0773441A1 Molecules that home to a selected organ or tissue in vivo and methods of identifying same
05/14/1997EP0773227A1 Diverse collections of oligomers in use to prepare drugs, diagnostic reagents, pesticides or herbicides
05/14/1997EP0772774A1 Determination of a specific immunoglobulin using multiple antigens
05/14/1997EP0772773A1 Src SH3 BINDING PEPTIDES AND METHODS OF ISOLATING AND USING SAME
05/14/1997EP0772633A1 Complexes for use in the diagnosis of vascular diseases
05/14/1997EP0772630A1 Streptogramine derivatives, preparation of same and pharmaceutical compositions containing same
05/14/1997EP0772629A1 T cell epitopes of rye grass pollen allergen
05/14/1997EP0772466A1 Compositions and methods for a bioartificial extracellular matrix
05/14/1997EP0772460A1 Radiolabeled compounds for thrombus imaging
05/14/1997EP0772459A1 TECHNETIUM-99m LABELED IMAGING AGENTS
05/14/1997EP0644894B1 Peptide for stimulation of cytotoxic t lymphocytes specific for hepatitis c virus
05/14/1997EP0644778B1 TECHNETIUM-99m LABELED PEPTIDES FOR IMAGING
05/14/1997EP0510132B1 Polymeric carriers for release of covalently linked agents
05/14/1997CN1149889A Isolated nucleic acid molecule with codes for tumor rejection antigen precursor and uses thereof
05/14/1997CN1149588A Cyclic bonding inhibitor
05/13/1997US5629293 Single chain peptide compounds having hemoregulatory activity
05/13/1997US5629292 Use of angiotensin III and analogs thereof in tissue repair
05/13/1997US5629290 Cyclic peptide antifungal agents
05/13/1997US5629289 Cyclic peptide antifungal agents
05/13/1997US5629288 Lipopeptide derivatives, a process for their preparation and their use
05/13/1997US5629196 DNA encoding peptide hormone that inhibits digestion in insects
05/13/1997US5629174 Dna, rna
05/13/1997US5629155 High-affinity oligonucleotide ligands to immunoglobulin E (IgE)
05/13/1997US5628986 Oral compositions
05/13/1997US5628979 Reagent for tumor imaging and therapy
05/09/1997WO1997016460A1 Casein fragments having growth promoting activity
05/09/1997WO1997016201A1 Angiotensin iv and analogs as regulators of fibrinolysis
05/09/1997CA2235670A1 Formation and use of prion protein (prp) complexes
05/07/1997EP0771818A2 Biotin derivatives
05/07/1997EP0771358A1 Isolated nucleic acid molecule which codes for a tumor rejection antigen precursor, and uses thereof
05/07/1997EP0771213A1 Haemophilus adherence and penetration proteins
05/07/1997EP0771210A1 TWO NON-CONTIGUOUS REGIONS CONTRIBUTE TO NIDOGEN BINDING TO A SINGLE EGF-LIKE MOTIF OF THE LAMININ $g(g)1 CHAIN
05/07/1997EP0771209A2 Novel peptides
05/07/1997EP0566571B1 Diagnosis of metastatic cancer by the mts-1 gene
05/07/1997EP0532716B1 New synthethic peptides with imunomodulating activity and preparation thereof
05/07/1997EP0464155B1 Endothelial cell growth factor, isolation and expression
05/07/1997CN1149257A Isolated tumor rejection antigen precursor mage-2 derived peptides, and uses thereof
05/06/1997USRE35500 Direct radiolabeling of antibodies and other proteins with technetium or rhenium
05/06/1997US5627262 Method and composition for the treatment of septic shock
05/06/1997US5627035 Peptides that block human immunodeficiency virus and methods of use thereof
05/06/1997US5626846 Contraceptive vaccine based on alloimmunization with zona pellucida polypeptides
05/02/1997EP0770679A2 HCV-specific peptides, preparations related to them and their use
05/02/1997EP0770624A2 Peptide capable of inducing immune response to human gastric cancer and agent containing it for preventing or treating human gastric cancer
05/02/1997EP0770622A2 Cyclic adhesion inhibitors
05/02/1997EP0770132A1 Streptogramines and method for preparing same by mutasynthesis
05/02/1997EP0770129A1 Zinc finger protein derivatives and methods therefor
05/02/1997EP0770127A1 Stem cell immobilisation
05/02/1997EP0770063A1 Technetium-sulphonamide complexes, their use, pharmaceutical agents containing them, and process for producing the complexes and agents
05/02/1997EP0769958A1 Inhibitors of leukocyte adhesion
05/02/1997EP0769956A1 Establishment of tonic ovarian estrogen secretion for extended therapeutic regimens
05/02/1997EP0627006B1 Hybrid dna that codes for a subunit of a bacterial toxin with a hemolysin
05/01/1997WO1997015598A1 Novel peptide
05/01/1997WO1997015590A1 Antitumor agents isolated from intestinal mucosa, a method for their isolation and their application
05/01/1997WO1997015589A1 Alpha-helix mimetics and methods relating thereto
05/01/1997WO1997015325A1 Pseudomonas exotoxin as immunogenic carrier in synthetic conjugate vaccines
05/01/1997WO1997015318A1 Peptide inhibitors of a phosphotyrosine-binding domain containing protein
05/01/1997WO1997015317A1 GnRH/REDUCED PSEUDOMONAS EXOTOXIN CONJUGATES
05/01/1997WO1997015316A1 Conjugates of gonadotropin releasing hormone
05/01/1997CA2235756A1 Peptide inhibitors of a phosphotyrosine-binding domain containing protein
05/01/1997CA2235510A1 Gnrh/reduced pseudomonas exotoxin conjugates
05/01/1997CA2233882A1 Pseudomonas exotoxin as immunogenic carrier in synthetic conjugate vaccines
05/01/1997CA2207846A1 Antitumor agents isolated from intestinal mucosa, a method for their isolation and their application
05/01/1997CA2204906A1 Neurotrophin antagonists
04/1997
04/30/1997CN1034735C Hemoregulating peptides
04/29/1997US5624902 Peptide inhibitors of calmodulin
04/29/1997US5624894 Brain-enhanced delivery of neuroactive peptides by sequential metabolism
04/29/1997US5624836 DNA encoding bovine pancreatic cholesterol esterase
04/24/1997WO1997014716A1 Cyclopeptide derivatives
04/24/1997WO1997014436A1 Synthetic vaccine for protection against human immunodeficiency virus infection
04/24/1997WO1997014426A1 Compositions and methods for enhancing immune responses mediated by antigen-presenting cells
04/24/1997WO1997014416A1 Conjugates useful in the treatment of benign prostatic hyperplasia
04/24/1997DE19538741A1 Cyclopeptidderivate Cyclopeptide derivatives
04/24/1997CA2235168A1 Synthetic vaccine for protection against human immunodeficiency virus infection
04/23/1997EP0769054A1 Immunomodulators
04/23/1997EP0769025A1 Diagnostic methods and compositions relating to the proteoglycan proteins of cartilage breakdown
04/23/1997EP0768888A1 Use of muramyl peptide compounds
04/23/1997EP0387276B1 Method to produce immunodiagnostic reagents
04/23/1997CN1148407A Modulators of anchoring protein function
04/23/1997CN1148393A Bradykinin antagonist peptides incorporating N-substituted glycines
04/23/1997CN1148391A Increased bioavailability of biologically active compounds by linking to polypyrrolecarboxamido-naphthalene derivatives